更新于：2024-12-10
Flurbiprofen Axetil
氟比洛芬酯
更新于：2024-12-10
概要
基本信息
非在研机构 |
最高研发阶段批准上市 |
最高研发阶段(中国)批准上市 |
特殊审评优先审评 (中国) |
登录后查看时间轴
结构
分子式C19H19FO4 |
InChIKeyALIVXCSEERJYHU-UHFFFAOYSA-N |
CAS号91503-79-6 |
关联
65
项与 氟比洛芬酯 相关的临床试验Effect of perioperative application of flurbiprofen axetil on postoperative acute kidney injury in high-risk elderly patients
评价氟比洛芬酯注射液用于治疗术后镇痛的多中心、随机、双盲、阳性药物平行对照的有效性及安全性的临床研究
评价氟比洛芬酯注射液用于术后镇痛的多中心、随机、双盲、平行、阳性对照临床试验
100 项与 氟比洛芬酯 相关的临床结果
登录后查看更多信息
100 项与 氟比洛芬酯 相关的转化医学
登录后查看更多信息
100 项与 氟比洛芬酯 相关的专利（医药）
登录后查看更多信息
183
项与 氟比洛芬酯 相关的文献（医药）2024-10-01ANAESTHESIA
Comparison of opioid‐free and opioid‐inclusive propofol anaesthesia for thyroid and parathyroid surgery: a randomised controlled trial
Article
作者: Zhu, Ya‐Juan ; Sun, Yan ; Ji, Fu‐Hai ; Wang, Dan ; Shan, Xi‐Sheng ; Liu, Hong ; Peng, Ke
Summary:
Background:
Postoperative nausea and vomiting occur frequently following thyroid and parathyroid surgery and are associated with worse patient outcomes. We hypothesised that opioid‐free propofol anaesthesia would reduce the incidence of postoperative nausea and vomiting compared with opioid‐inclusive propofol anaesthesia in patients undergoing these procedures.
Methods:
We conducted a randomised, double‐blinded controlled trial in adult patients scheduled to undergo thyroid and parathyroid surgery at two medical centres in mainland China. Patients were allocated randomly (1:1, stratified by sex and trial site) to an opioid‐free anaesthesia group (esketamine, lidocaine, dexmedetomidine and propofol) or an opioid‐inclusive group (sufentanil and propofol). Propofol infusions were titrated to bispectral index 45–55. Patients received prophylaxis for nausea and vomiting using dexamethasone and ondansetron and multimodal analgesia with paracetamol and flurbiprofen axetil. The primary outcome was the incidence of postoperative nausea and vomiting in the first 48 h after surgery.
Results:
We assessed 557 patients for eligibility and 394 completed this trial. The incidence of postoperative nausea and vomiting in the first postoperative 48 h was lower in the opioid‐free anaesthesia group (10/197, 5%) compared with opioid‐inclusive group (47/197, 24%) (OR (95%CI) 0.17 (0.08–0.35), p < 0.001), yielding a number needed to treat of 5.3. Additionally, opioid‐free propofol anaesthesia was associated with a reduced need for rescue anti‐emetics, lower rates of hypotension and desaturation after tracheal extubation, and higher patient satisfaction. Time to tracheal extubation was prolonged slightly in the opioid‐free group. The two groups had similar postoperative pain scores and 30‐day outcomes.
Discussion:
Opioid‐free propofol anaesthesia reduced postoperative nausea and vomiting in patients undergoing thyroid and parathyroid surgery. An opioid‐free anaesthetic regimen can optimise anaesthetic care during thyroid and parathyroid surgery.
2024-07-02Zhonghua yi xue za zhi
[Effectiveness and safety of multimodal analgesia in open gastrostomy in patients with end-stage head and neck cancer].
Article
作者: Wang, G Y ; Hu, C H ; Chen, Y M ; Yuan, S ; Chen, H Y ; Wu, L L
Objective: To investigate the effectiveness and safety of multimodal analgesia in patients with end-stage head and neck cancer in open gastrostomy surgery. Methods: This was a randomized controlled trial. From June to December 2023, 50 patients with end-stage head and neck cancer who underwent elective open gastrostomy surgery in Beijing Tongren Hospital Affiliated to Capital Medical University were prospectively selected. The patients were divided into multimodal analgesia group and local anesthesia group using the random number table method according to different anesthesia methods, with 25 cases in each group. In multimodal analgesia group, a multimodal analgesia regimen was adopted: ultrasound-guided abdominal wall nerve block (rectus sheath block and transverse abdominis plane block)+intravenous injection of oxycodone+intravenous injection of flurbiprofen axetil and dexamethasone. In local anesthesia group, local infiltration anesthesia with ropivacaine was adopted. The main outcome measure was the incidence of intraoperative pain numeric rating scale (NRS) score>3 points in the two groups. The secondary observation indicators included NRS score and hemodynamic indexes [mean arterial pressure (MAP) and heart rate (HR)] at various time points during surgery [before anesthesia (T0), at the time of incision (T1), 10 minutes after surgery (T2), during gastric body traction (T3), and at the end of surgery (T4)], incidence of adverse reactions, postoperative patient satisfaction score, as well as the NRS scores at rest and activity (coughing) within 24 hours after surgery. Results: The multimodal analgesia group included 21 males and 4 females, aged (61.4±9.9) years. There were 19 males and 6 females in the local anesthesia group, aged (58.6±10.8) years. The incidence of intraoperative NRS score>3 points and the incidence of salvage analgesia in the multimodal analgesia group were both 12.0% (3/25), which were lower than 60.0% (15/25) in the local anesthesia group, and the differences were statistically significant (all P<0.001); The NRS score [M (Q1, Q3)] at T3 in the multimodal analgesia group was 2 (2, 3) points, which were lower than 5 (3, 6) points in the local anesthesia group (P<0.05). There were smaller variabilities in MAP and HR in the multimodal analgesia group than those in the local anesthesia group (all P<0.05). The incidence of intraoperative tachycardia, surgical traction reaction, and nausea in the multimodal analgesia group was lower than that in the local anesthesia group (all P<0.05). The postoperative satisfaction score of patients in the multimodal analgesia group was (9.25±0.71) points, which were higher than (7.33±0.87) points in the local anesthesia group (P<0.001). NRS score during postoperative activity within 24 hours in the multimodal analgesia group were (2.36±0.75) points, which were lower than (3.03±0.81) points of the local anesthesia group (P=0.005). No adverse reactions such as urinary retention, nausea, vomiting and dizziness occurred in both groups. Conclusion: Compared with local anesthesia, the multimodal analgesic strategy could provide better analgesic effect and longer duration, better hemodynamic stability, and fewer intraoperative adverse reactions in patients with end-stage head and neck cancer undergoing open gastrostomy.
2024-06-01Journal of orthopaedics
Analgesic effect and safety of a half-dose transdermal buprenorphine patch after arthroscopic rotator cuff repair
Article
作者: Sheng, Jing ; Yan, Yingzhao ; Ni, Libin ; Qu, Hangbo ; Ru, Xuanliang ; Fu, Yang
Objective:
To retrospectively explore the effect of a half-dose buprenorphine transdermal patch for analgesia after arthroscopic rotator cuff repair (ARCR).
Methods:
This analysis was performed with clinical data from patients who received unilateral ARCR in our hospital between October 2017 and December 2020. The patients were divided into three groups (30 cases each). In group A (control group), 100 mg flurbiprofen axetil (FA) was administered twice a day for 5 days after surgery. In group B (experimental group), 100 mg FA was administered twice a day for 5 days and half (2.5 mg) of a buprenorphine transdermal patch was applied after surgery; an additional half (2.5 mg) patch was applied 3 days later. In group C (condition control group), 100 mg FA was administered twice a day for 5 days and a 5-mg patch was applied directly after surgery. The visual analog scale (VAS) was administered repeatedly 1 day before surgery and 1, 2, 3, 5, and 14 days after surgery in each group. The simple shoulder test (SST) score, range of shoulder forward elevation (FE), and external rotation (ER) were recorded preoperatively and 12 weeks postoperatively.
Results:
VAS scores on postoperative days 3 and 5 were significantly lower in groups B and C than in group A (p < 0.05). The VAS score on postoperative day 14 was significantly lower in group C than in group A (p < 0.05). The difference in VAS score between groups B and C was not significant (p > 0.05). All patients had significantly improved VAS scores, SST scores, FE, and ER at 12 weeks postoperatively.
Conclusion:
The half-dose buprenorphine transdermal patch had a good analgesic effect with minimal side effects after ARCR and did not delay the recovery of shoulder joint function.
100 项与 氟比洛芬酯 相关的药物交易
登录后查看更多信息
研发状态
批准上市
10 条最早获批的记录, 后查看更多信息
登录
| 适应症 | 国家/地区 | 公司 | 日期 |
|---|---|---|---|
| 癌症疼痛 | 日本 | 1992-03-27 | |
| 术后疼痛 | 日本 | 1992-03-27 |
未上市
10 条进展最快的记录, 后查看更多信息
登录
| 适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
|---|---|---|---|---|
| 疼痛 | 临床3期 | 中国 | 2018-01-02 | |
| 急性发热 | 临床2期 | 中国 | 2017-12-29 | |
| 急性发热 | 临床2期 | 中国 | 2017-12-29 |
登录后查看更多信息
临床结果
临床结果
适应症
分期
评价
查看全部结果
N/A | - | 200 | 蓋鑰選觸鬱鬱選願範餘(鏇遞構積艱遞製鑰廠顧) = 醖範構襯鹹繭鏇繭憲艱 鏇鹹艱憲積鹽鏇鹽願繭 (糧淵蓋襯鑰淵積壓壓選 ) 更多 | 积极 | 2017-10-01 | ||
Placebo | 蓋鑰選觸鬱鬱選願範餘(鏇遞構積艱遞製鑰廠顧) = 獵構築鑰鬱遞繭衊範積 鏇鹹艱憲積鹽鏇鹽願繭 (糧淵蓋襯鑰淵積壓壓選 ) 更多 | ||||||
N/A | 180 | (Normal Saline) | 鑰艱壓築窪鹹網齋製顧(鑰鏇餘簾齋鹹艱觸艱願) = 憲製壓淵鑰簾鬱壓廠襯 構範艱糧鹽齋範遞蓋積 (憲獵夢壓範顧齋糧艱鏇, 鹽齋製壓襯膚壓衊鹹簾 ~ 積繭衊網簾範製獵膚鬱) 更多 | - | 2015-09-28 | ||
(Flurbiprofen AxetilⅠ) | 鑰艱壓築窪鹹網齋製顧(鑰鏇餘簾齋鹹艱觸艱願) = 鬱蓋衊獵範襯壓窪遞廠 構範艱糧鹽齋範遞蓋積 (憲獵夢壓範顧齋糧艱鏇, 鹽夢簾憲糧襯鏇夢選獵 ~ 顧遞蓋餘網顧鹽鏇鏇繭) 更多 |
登录后查看更多信息
转化医学
使用我们的转化医学数据加速您的研究。
登录
或
药物交易
使用我们的药物交易数据加速您的研究。
登录
或
核心专利
使用我们的核心专利数据促进您的研究。
登录
或
临床分析
紧跟全球注册中心的最新临床试验。
登录
或
批准
利用最新的监管批准信息加速您的研究。
登录
或
特殊审评
只需点击几下即可了解关键药物信息。
登录
或
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。
生物序列数据库
生物药研发创新
免费使用
化学结构数据库
小分子化药研发创新
免费使用